Magnesium is an indispensable mineral that supports various bodily functions, including muscle and nerve health, immune ...

The yearly price cap has been in the works since President Joe Biden signed the Inflation Reduction Act into law in 2022, with that legislation including provisions tackling drug costs for seniors ...

While the New Year's tradition of drug price hikes has held firm for years, pharma companies have decidedly tamped down on the magnitude of cost increases getting rolled out Jan. 1. All told ...

Substance abuse in the United States is one of the leading health conditions impacting millions of lives and due to many types of drug addictions. Since 2000, there have been 700,000 overdose deaths ...

Lenz noted the “contrast” in drug and placebo responses in depressed mood and anhedonia in female participants compared to male participants. The change from baseline on MADRS was -14 for female ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for ... [+] health insurers, employers and government health programs who cover it in 2025.

SAN FRANCISCO — After surging during the COVID pandemic into a crushing public health emergency, drug overdose deaths in San Francisco plummeted in 2024, according to preliminary data compiled ...

(eClinicalMedicine) A systematic review delved into how SARS-CoV-2 infection impacts the thyroid. (Frontiers in ... to cut the list price of its diabetes drugs sitagliptin (Januvia) and ...

REUTERS/Dado Ruvic/Illustration/File Photo Nearly all of the drug price increases are below 10%—most well below. The median price increase of the drugs being hiked Jan. 1 is 4.5%, which is in ...

The U.S. Food and Drug Administration (FDA) has granted approval for Zepbound, a weight-loss medication, to treat moderate to severe obstructive sleep apnea (OSA) in individuals with obesity.

"They make this drug in Denmark, and in Denmark they do not recommend it for diabetes, or for obesity. They recommend dietary and behavioral changes." "They're counting on selling it to Americans ...

Yesterday, the ABC reported on a possible class action looming over the increased risk of benign brain tumours caused by long-term use of the drug. However, several women claim their health has ...